| Glenmark Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532296 |
NSE Symbol : GLENMARK |
P/E(TTM) : 37.18 |
|
ISIN Demat : INE935A01035 |
Div & Yield% : 0.13 |
EPS(TTM) : 52.14 |
|
Book Value(₹) : 848.31 |
Market Cap(₹Cr) : 54,700.39 |
Face Value(₹) : 1.00 |
| Board Of Directors | |
|---|---|
| Chairman / Executive Director / M D / Promoter |
Glenn Saldanha
|
| Company Sec. & Compli. Officer |
Harish Kuber
|
| ED / President / Global CFO |
Anurag Mantri
|
| ED / WTD / Promoter |
Cheryl Pinto
|
| Independent Non Exe. Director |
Sona Saira Ramasastry
Dipankar Bhattacharjee
V R Iyer
Pradeep Kumar Sinha
|
| Non Executive Director |
B E Saldanha
|